Search - tctmd.com

Displaying 161 - 180 of 415

Sort: Relevancy | Date

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

News Daily News

RV Strain a Prognostic Marker for Mortality in COVID-19

Caitlin E. Cox

May 04, 2020

News Conference News ACC 2020

Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair

L.A. McKeown

April 07, 2020

News Conference News ACC 2020

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Michael O'Riordan

March 29, 2020

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Daily News

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Yael L. Maxwell

February 28, 2020

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

News Daily News

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Yael L. Maxwell

February 14, 2020

News Daily News

ACS After TAVR a Unique Condition With Poor Prognosis

Todd Neale

February 05, 2020

News Features

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Shelley Wood

December 23, 2019

News Daily News

Routine Anticoagulation Seems Warranted After TMVR: Review

Todd Neale

December 04, 2019

News Conference News PCR London Valves 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Michael O'Riordan

November 20, 2019

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

Todd Neale

November 17, 2019

Podcast TCTMD Talking Points

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

October 25, 2019

Presentation TCT Abstracts Posters 2019

Transcatheter Mitral Valve Position Affects Risk of Valve Thrombosis Following TMVR Procedure.

Presenter: Saba Ravaghi

October 02, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Presenter: Raj Makkar

September 27, 2019

Advertisement

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

RV Strain a Prognostic Marker for Mortality in COVID-19

Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

ACS After TAVR a Unique Condition With Poor Prognosis

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Routine Anticoagulation Seems Warranted After TMVR: Review

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Transcatheter Mitral Valve Position Affects Risk of Valve Thrombosis Following TMVR Procedure.

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content